Condition
Serum; Disease
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Unknown2
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04426006Not ApplicableCompleted
Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic
NCT04152005CompletedPrimary
Endothelin Concentrations in a Population With Cardiovascular Disease and Periodonitis
NCT03180775Not ApplicableUnknown
Effects of Dietary Amino Acids on Serum and Macrophage Atherogenicity
NCT02894931Not ApplicableUnknown
Effects of Dietary Interventions on Serum and Macrophage Atherogenicity
Showing all 4 trials